PEPGEN INC. Operating Lease, Payments
PEPGEN INC. (PEPG) reported Operating Lease, Payments of $3.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-24.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2025-02-24
- PEPGEN INC. operating lease, payments for the quarter ending 2023-12-31 was $737.00K.
- PEPGEN INC. operating lease, payments for the quarter ending 2023-09-30 was $1.26M.
- PEPGEN INC. operating lease, payments for the quarter ending 2022-03-31 was $2.89M.
- PEPGEN INC. operating lease, payments for fiscal 2024 was $3.00M, a 43.31% decline from fiscal 2023.
- PEPGEN INC. operating lease, payments for fiscal 2023 was $5.30M, a 162.85% increase from fiscal 2022.
- PEPGEN INC. operating lease, payments for fiscal 2022 was $2.02M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2024-12-31 | $3.00M 10-K · filed 2025-02-24 | |||
| 2023-12-31 | $737.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-03-29 | $1.99M derived: sum of 2 quarters · filed 2024-03-29 | $5.30M 10-K/A · filed 2024-03-29 | |
| 2023-09-30 | $1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $4.56M 10-Q · filed 2023-11-08 | ||
| 2023-06-30 | $3.31M 10-Q · filed 2023-08-08 | |||
| 2022-12-31 | $2.02M 10-K · filed 2023-03-23 | |||
| 2022-03-31 | $2.89M 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |